ClinicalTrials.gg
Sign In

Tachycardia, Ventricular clinical trials

The registry lists 451 studies for Tachycardia, Ventricular across more than 10 countries. 120 are recruiting or about to start. 288 of them are mainly about Tachycardia, Ventricular (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

Get an email when these change. Save the Tachycardia, Ventricular studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
202
Recruiting
85
Status unknown
50
Terminated
43
Not yet recruiting
27
Active, not recruiting
18

Phase

Phase 4
32
Phase 3
28
Phase 2
22
Phase 1
11
Early Phase 1
4

Where

United States
154
Germany
61
Canada
54
Italy
44
France
42
United Kingdom
38

Who runs them

Biotronik SE & Co. KG (17) · Abbott Medical Devices (16) · Boston Scientific Corporation (16) · Medtronic Cardiac Rhythm and Heart Failure (14) · Milestone Pharmaceuticals Inc. (7) · Biosense Webster, Inc. (6) · John Sapp (6) · Stereotaxis (5)

What is being tested here

Drugs under test in Tachycardia, Ventricular studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Ethanol112
CRD-4730102
Mirabegron101
Dexmedetomidine111
Etripamil035
Amiodarone014
Ranolazine013
Dantrolene011
Rivaroxaban001
Dexamethasone001

Drug classes tested here Calcium channel blockers 6

Coming up

5phase 3 studies under way
37studies finish main data collection within a year2 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 85 Tachycardia, Ventricular studies recruiting now, 66 (78%) set no upper age limit and 1 (1%) stop at 75 or younger. 7 (8%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 5 (6%) take healthy volunteers.

Recruiting studies that take each age, of 85
AgeWomenMen
106 (7%)6 (7%)
1879 (93%)79 (93%)
3082 (96%)82 (96%)
4082 (96%)82 (96%)
5083 (98%)83 (98%)
6584 (99%)84 (99%)
7584 (99%)84 (99%)
8579 (93%)79 (93%)

Across all 451 studies, recruiting or not: 6% stop at 75 or younger and 2% at 65; 9% take children; <1% are for women only and <1% for men only; 4% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Tachycardia, Ventricular studies take

Of 125 interventional studies with no phase under Tachycardia, Ventricular, half reached primary completion within 36 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase36 mo20–66 · 125 studies31 mo6–52 · 40 studies37 mo25–70 · 85 studies
Observational46 mo28–108 · 69 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting1

Results posted1

Newly registered3

Studies

Recruiting first, then most recently updated. Showing 50 of 451. Browse all 451 → or search them.